Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation
- 1 January 1987
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 113 (1), 129-137
- https://doi.org/10.1016/0002-8703(87)90020-2
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarctionJournal of the American College of Cardiology, 1983
- Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation, 1983
- Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs.Circulation Research, 1981
- Prostacyclin in experimental myocardial ischemia: Effects on hemodynamics, regional myocardial blood flow, infarct size and mortalityThe American Journal of Cardiology, 1981
- Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart.Circulation Research, 1980
- Studies on the protective effect of prostacyclin in acute myocardial ischemiaEuropean Journal of Pharmacology, 1979
- Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial IschemiaScience, 1978
- Cardiovascular responses to PGI2 (prostacyclin) in the dog.Circulation Research, 1978
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976